Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HIVEP1
|
ENSG00000095951.12 | HIVEP zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIVEP1 | hg19_v2_chr6_+_12012536_12012571 | 0.32 | 7.5e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106791536 | 6.52 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr14_-_107049312 | 5.70 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
chr12_-_9913489 | 5.54 |
ENST00000228434.3
ENST00000536709.1 |
CD69
|
CD69 molecule |
chr14_-_106322288 | 5.07 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr22_+_22930626 | 4.80 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
chr2_+_219745020 | 4.76 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
chr14_-_106622419 | 4.55 |
ENST00000390604.2
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional) |
chr14_-_106518922 | 4.36 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
chr14_-_106866934 | 4.06 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
chr14_-_106586656 | 3.73 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
chr14_-_106725723 | 3.60 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
chr14_-_106573756 | 3.44 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
chr2_+_89999259 | 3.27 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr3_-_58196939 | 3.18 |
ENST00000394549.2
ENST00000461914.3 |
DNASE1L3
|
deoxyribonuclease I-like 3 |
chrX_+_78426469 | 3.04 |
ENST00000276077.1
|
GPR174
|
G protein-coupled receptor 174 |
chr14_-_106845789 | 2.95 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
chr3_-_58196688 | 2.82 |
ENST00000486455.1
|
DNASE1L3
|
deoxyribonuclease I-like 3 |
chr2_+_162101247 | 2.78 |
ENST00000439050.1
ENST00000436506.1 |
AC009299.3
|
AC009299.3 |
chr4_+_155484103 | 2.67 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
chr16_-_33647696 | 2.63 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
chr16_+_33020496 | 2.60 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
chr17_-_18950950 | 2.59 |
ENST00000284154.5
|
GRAP
|
GRB2-related adaptor protein |
chr9_+_127054217 | 2.52 |
ENST00000394199.2
ENST00000546191.1 |
NEK6
|
NIMA-related kinase 6 |
chr4_+_155484155 | 2.48 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
chr6_+_31554962 | 2.47 |
ENST00000376092.3
ENST00000376086.3 ENST00000303757.8 ENST00000376093.2 ENST00000376102.3 |
LST1
|
leukocyte specific transcript 1 |
chr19_-_6591113 | 2.46 |
ENST00000423145.3
ENST00000245903.3 |
CD70
|
CD70 molecule |
chr4_-_109087906 | 2.43 |
ENST00000515500.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr17_-_46623441 | 2.35 |
ENST00000330070.4
|
HOXB2
|
homeobox B2 |
chr16_+_33006369 | 2.34 |
ENST00000425181.3
|
IGHV3OR16-10
|
immunoglobulin heavy variable 3/OR16-10 (non-functional) |
chr6_+_31555045 | 2.32 |
ENST00000396101.3
ENST00000490742.1 |
LST1
|
leukocyte specific transcript 1 |
chr14_-_107114267 | 2.32 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
chr3_-_111852061 | 2.31 |
ENST00000488580.1
ENST00000460387.2 ENST00000484193.1 ENST00000487901.1 |
GCSAM
|
germinal center-associated, signaling and motility |
chr14_+_22356029 | 2.31 |
ENST00000390437.2
|
TRAV12-2
|
T cell receptor alpha variable 12-2 |
chr22_-_37640277 | 2.30 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr16_+_85936295 | 2.30 |
ENST00000563180.1
ENST00000564617.1 ENST00000564803.1 |
IRF8
|
interferon regulatory factor 8 |
chr16_+_32063311 | 2.27 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
chr14_+_22573582 | 2.25 |
ENST00000390453.1
|
TRAV24
|
T cell receptor alpha variable 24 |
chr12_-_57871853 | 2.20 |
ENST00000549602.1
ENST00000430041.2 |
ARHGAP9
|
Rho GTPase activating protein 9 |
chr16_+_33605231 | 2.18 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
chr16_+_32077386 | 2.15 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr6_+_32709119 | 2.13 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chr22_-_37640456 | 2.12 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chrX_+_47444613 | 2.11 |
ENST00000445623.1
|
TIMP1
|
TIMP metallopeptidase inhibitor 1 |
chr14_-_106610852 | 2.11 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
chr14_+_22433675 | 2.11 |
ENST00000390442.3
|
TRAV12-3
|
T cell receptor alpha variable 12-3 |
chr3_-_156878482 | 2.10 |
ENST00000295925.4
|
CCNL1
|
cyclin L1 |
chr14_-_107199464 | 2.09 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
chr3_-_111852128 | 2.08 |
ENST00000308910.4
|
GCSAM
|
germinal center-associated, signaling and motility |
chr7_-_150497406 | 2.08 |
ENST00000492607.1
ENST00000326442.5 ENST00000450753.2 |
TMEM176B
|
transmembrane protein 176B |
chr12_-_57871825 | 2.07 |
ENST00000548139.1
|
ARHGAP9
|
Rho GTPase activating protein 9 |
chr3_-_156878540 | 2.06 |
ENST00000461804.1
|
CCNL1
|
cyclin L1 |
chr1_+_156119466 | 2.06 |
ENST00000414683.1
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr14_+_22689792 | 2.05 |
ENST00000390462.1
|
TRAV35
|
T cell receptor alpha variable 35 |
chr19_-_42636543 | 2.03 |
ENST00000528894.4
ENST00000560804.2 ENST00000560558.1 ENST00000560398.1 ENST00000526816.2 |
POU2F2
|
POU class 2 homeobox 2 |
chr22_+_37257015 | 2.03 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
chr14_+_75988768 | 1.99 |
ENST00000286639.6
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
chr14_+_22788560 | 1.99 |
ENST00000390468.1
|
TRAV41
|
T cell receptor alpha variable 41 |
chr12_+_7055631 | 1.99 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr5_-_39219705 | 1.97 |
ENST00000351578.6
|
FYB
|
FYN binding protein |
chr14_+_22771851 | 1.95 |
ENST00000390466.1
|
TRAV39
|
T cell receptor alpha variable 39 |
chr19_-_10445399 | 1.94 |
ENST00000592945.1
|
ICAM3
|
intercellular adhesion molecule 3 |
chr7_+_150497569 | 1.92 |
ENST00000004103.3
|
TMEM176A
|
transmembrane protein 176A |
chr1_-_202129105 | 1.89 |
ENST00000367279.4
|
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr19_-_49843539 | 1.88 |
ENST00000602554.1
ENST00000358234.4 |
CTC-301O7.4
|
CTC-301O7.4 |
chr4_+_86748898 | 1.87 |
ENST00000509300.1
|
ARHGAP24
|
Rho GTPase activating protein 24 |
chr5_+_49962495 | 1.86 |
ENST00000515175.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr11_-_104893863 | 1.86 |
ENST00000260315.3
ENST00000526056.1 ENST00000531367.1 ENST00000456094.1 ENST00000444749.2 ENST00000393141.2 ENST00000418434.1 ENST00000393139.2 |
CASP5
|
caspase 5, apoptosis-related cysteine peptidase |
chr1_+_54359854 | 1.85 |
ENST00000361921.3
ENST00000322679.6 ENST00000532493.1 ENST00000525202.1 ENST00000524406.1 ENST00000388876.3 |
DIO1
|
deiodinase, iodothyronine, type I |
chr7_-_150497621 | 1.81 |
ENST00000434545.1
|
TMEM176B
|
transmembrane protein 176B |
chr7_+_150497491 | 1.81 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
chr4_+_86749045 | 1.79 |
ENST00000514229.1
|
ARHGAP24
|
Rho GTPase activating protein 24 |
chr14_-_23292596 | 1.79 |
ENST00000554741.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr8_+_24241789 | 1.79 |
ENST00000256412.4
ENST00000538205.1 |
ADAMDEC1
|
ADAM-like, decysin 1 |
chr22_+_50986462 | 1.78 |
ENST00000395676.2
|
KLHDC7B
|
kelch domain containing 7B |
chr6_-_32908792 | 1.77 |
ENST00000418107.2
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
chr12_-_55367361 | 1.76 |
ENST00000532804.1
ENST00000531122.1 ENST00000533446.1 |
TESPA1
|
thymocyte expressed, positive selection associated 1 |
chr9_+_139921916 | 1.75 |
ENST00000314330.2
|
C9orf139
|
chromosome 9 open reading frame 139 |
chr4_-_74864386 | 1.73 |
ENST00000296027.4
|
CXCL5
|
chemokine (C-X-C motif) ligand 5 |
chr6_+_31554779 | 1.73 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
chr9_-_136344197 | 1.69 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr9_+_127054254 | 1.69 |
ENST00000422297.1
|
NEK6
|
NIMA-related kinase 6 |
chr5_-_39219641 | 1.67 |
ENST00000509072.1
ENST00000504542.1 ENST00000505428.1 ENST00000506557.1 |
FYB
|
FYN binding protein |
chr19_-_52133588 | 1.65 |
ENST00000570106.2
|
SIGLEC5
|
sialic acid binding Ig-like lectin 5 |
chr1_+_37940153 | 1.61 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
chr14_-_106926724 | 1.61 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
chr2_-_169887827 | 1.58 |
ENST00000263817.6
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
chr11_+_18287721 | 1.58 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
chr14_+_75988851 | 1.57 |
ENST00000555504.1
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
chr14_+_103589789 | 1.56 |
ENST00000558056.1
ENST00000560869.1 |
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr9_-_116837249 | 1.56 |
ENST00000466610.2
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
chr11_+_116700600 | 1.55 |
ENST00000227667.3
|
APOC3
|
apolipoprotein C-III |
chr11_+_116700614 | 1.55 |
ENST00000375345.1
|
APOC3
|
apolipoprotein C-III |
chr11_+_18287801 | 1.54 |
ENST00000532858.1
ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
chr4_-_109087872 | 1.54 |
ENST00000510624.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr12_-_55367331 | 1.49 |
ENST00000526532.1
ENST00000532757.1 |
TESPA1
|
thymocyte expressed, positive selection associated 1 |
chr6_+_31554826 | 1.49 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
chr6_-_31324943 | 1.49 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr3_-_119278446 | 1.49 |
ENST00000264246.3
|
CD80
|
CD80 molecule |
chr13_-_46756351 | 1.48 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr1_-_204436344 | 1.48 |
ENST00000367184.2
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
chr2_-_88427568 | 1.46 |
ENST00000393750.3
ENST00000295834.3 |
FABP1
|
fatty acid binding protein 1, liver |
chr14_+_22675388 | 1.46 |
ENST00000390461.2
|
TRAV34
|
T cell receptor alpha variable 34 |
chr11_+_71846764 | 1.46 |
ENST00000456237.1
ENST00000442948.2 ENST00000546166.1 |
FOLR3
|
folate receptor 3 (gamma) |
chr6_-_31239846 | 1.45 |
ENST00000415537.1
ENST00000376228.5 ENST00000383329.3 |
HLA-C
|
major histocompatibility complex, class I, C |
chr6_+_29691056 | 1.43 |
ENST00000414333.1
ENST00000334668.4 ENST00000259951.7 |
HLA-F
|
major histocompatibility complex, class I, F |
chr7_+_142494795 | 1.42 |
ENST00000390417.1
|
TRBJ2-5
|
T cell receptor beta joining 2-5 |
chr8_+_24241969 | 1.41 |
ENST00000522298.1
|
ADAMDEC1
|
ADAM-like, decysin 1 |
chr18_-_2982869 | 1.41 |
ENST00000584915.1
|
LPIN2
|
lipin 2 |
chr11_+_71846748 | 1.40 |
ENST00000445078.2
|
FOLR3
|
folate receptor 3 (gamma) |
chr6_-_74231303 | 1.37 |
ENST00000309268.6
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1 |
chr11_-_75062730 | 1.34 |
ENST00000420843.2
ENST00000360025.3 |
ARRB1
|
arrestin, beta 1 |
chr10_-_125851961 | 1.34 |
ENST00000346248.5
|
CHST15
|
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
chr8_+_27169138 | 1.34 |
ENST00000522338.1
|
PTK2B
|
protein tyrosine kinase 2 beta |
chr16_-_20556492 | 1.33 |
ENST00000568098.1
|
ACSM2B
|
acyl-CoA synthetase medium-chain family member 2B |
chr16_+_72088376 | 1.32 |
ENST00000570083.1
ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP
HPR
|
haptoglobin haptoglobin-related protein |
chrX_-_30595959 | 1.32 |
ENST00000378962.3
|
CXorf21
|
chromosome X open reading frame 21 |
chr2_+_61108771 | 1.31 |
ENST00000394479.3
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
chr13_-_46964177 | 1.31 |
ENST00000389908.3
|
KIAA0226L
|
KIAA0226-like |
chr11_+_57227981 | 1.31 |
ENST00000335099.3
|
RTN4RL2
|
reticulon 4 receptor-like 2 |
chr6_+_29691198 | 1.30 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr7_+_142495131 | 1.30 |
ENST00000390419.1
|
TRBJ2-7
|
T cell receptor beta joining 2-7 |
chr6_-_74231444 | 1.29 |
ENST00000331523.2
ENST00000356303.2 |
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1 |
chr6_-_74230741 | 1.29 |
ENST00000316292.9
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1 |
chr2_+_202047843 | 1.28 |
ENST00000272879.5
ENST00000374650.3 ENST00000346817.5 ENST00000313728.7 ENST00000448480.1 |
CASP10
|
caspase 10, apoptosis-related cysteine peptidase |
chr17_+_40440481 | 1.28 |
ENST00000590726.2
ENST00000452307.2 ENST00000444283.1 ENST00000588868.1 |
STAT5A
|
signal transducer and activator of transcription 5A |
chr22_+_50919944 | 1.28 |
ENST00000395738.2
|
ADM2
|
adrenomedullin 2 |
chr5_+_40679584 | 1.27 |
ENST00000302472.3
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4) |
chr17_-_34207295 | 1.27 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr22_-_37215523 | 1.27 |
ENST00000216200.5
|
PVALB
|
parvalbumin |
chr17_-_53499310 | 1.26 |
ENST00000262065.3
|
MMD
|
monocyte to macrophage differentiation-associated |
chr12_-_14133053 | 1.25 |
ENST00000609686.1
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
chr19_+_4229495 | 1.25 |
ENST00000221847.5
|
EBI3
|
Epstein-Barr virus induced 3 |
chr9_-_131486367 | 1.25 |
ENST00000372663.4
ENST00000406904.2 ENST00000452105.1 ENST00000372672.2 ENST00000372667.5 |
ZDHHC12
|
zinc finger, DHHC-type containing 12 |
chr1_-_206671061 | 1.25 |
ENST00000367119.1
|
C1orf147
|
chromosome 1 open reading frame 147 |
chr3_-_119278376 | 1.25 |
ENST00000478182.1
|
CD80
|
CD80 molecule |
chr11_-_57194111 | 1.25 |
ENST00000529112.1
ENST00000529896.1 |
SLC43A3
|
solute carrier family 43, member 3 |
chr1_+_156117149 | 1.24 |
ENST00000435124.1
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chrX_-_48326764 | 1.23 |
ENST00000413668.1
ENST00000441948.1 |
SLC38A5
|
solute carrier family 38, member 5 |
chr7_+_98971863 | 1.21 |
ENST00000443222.1
ENST00000414376.1 |
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
chr8_+_27168988 | 1.21 |
ENST00000397501.1
ENST00000338238.4 ENST00000544172.1 |
PTK2B
|
protein tyrosine kinase 2 beta |
chr17_-_26876350 | 1.21 |
ENST00000470125.1
|
UNC119
|
unc-119 homolog (C. elegans) |
chr2_-_74781061 | 1.20 |
ENST00000264094.3
ENST00000393937.2 ENST00000409986.1 |
LOXL3
|
lysyl oxidase-like 3 |
chr6_+_32407619 | 1.20 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
chr14_+_52313833 | 1.19 |
ENST00000553560.1
|
GNG2
|
guanine nucleotide binding protein (G protein), gamma 2 |
chr6_-_30128657 | 1.19 |
ENST00000449742.2
ENST00000376704.3 |
TRIM10
|
tripartite motif containing 10 |
chr1_-_8000872 | 1.18 |
ENST00000377507.3
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9 |
chr15_+_90728145 | 1.17 |
ENST00000561085.1
ENST00000379122.3 ENST00000332496.6 |
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr3_+_52821841 | 1.17 |
ENST00000405128.3
|
ITIH1
|
inter-alpha-trypsin inhibitor heavy chain 1 |
chr11_-_75062829 | 1.17 |
ENST00000393505.4
|
ARRB1
|
arrestin, beta 1 |
chr4_+_39046615 | 1.16 |
ENST00000261425.3
ENST00000508137.2 |
KLHL5
|
kelch-like family member 5 |
chr2_-_235405679 | 1.15 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr6_-_31704282 | 1.15 |
ENST00000375784.3
ENST00000375779.2 |
CLIC1
|
chloride intracellular channel 1 |
chr7_-_22259845 | 1.14 |
ENST00000420196.1
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr19_+_41869894 | 1.13 |
ENST00000413014.2
|
TMEM91
|
transmembrane protein 91 |
chr1_-_236030216 | 1.13 |
ENST00000389794.3
ENST00000389793.2 |
LYST
|
lysosomal trafficking regulator |
chr11_-_64510409 | 1.12 |
ENST00000394429.1
ENST00000394428.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr22_+_50919995 | 1.10 |
ENST00000362068.2
ENST00000395737.1 |
ADM2
|
adrenomedullin 2 |
chr16_-_74734742 | 1.10 |
ENST00000308807.7
ENST00000573267.1 |
MLKL
|
mixed lineage kinase domain-like |
chr1_+_156123359 | 1.10 |
ENST00000368284.1
ENST00000368286.2 ENST00000438830.1 |
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr6_+_32605195 | 1.09 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr11_-_67276100 | 1.08 |
ENST00000301488.3
|
CDK2AP2
|
cyclin-dependent kinase 2 associated protein 2 |
chr11_+_842808 | 1.07 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
chr15_+_91411810 | 1.07 |
ENST00000268171.3
|
FURIN
|
furin (paired basic amino acid cleaving enzyme) |
chr22_+_42834029 | 1.07 |
ENST00000428765.1
|
CTA-126B4.7
|
CTA-126B4.7 |
chr14_+_95982451 | 1.06 |
ENST00000554161.1
|
RP11-1070N10.3
|
Uncharacterized protein |
chr12_-_57504069 | 1.05 |
ENST00000543873.2
ENST00000554663.1 ENST00000557635.1 |
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr5_-_18746250 | 1.05 |
ENST00000512978.1
|
CTD-2023M8.1
|
CTD-2023M8.1 |
chr12_-_48298785 | 1.05 |
ENST00000550325.1
ENST00000546653.1 ENST00000549336.1 ENST00000535672.1 ENST00000229022.3 ENST00000548664.1 |
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor |
chr6_+_31554456 | 1.04 |
ENST00000339530.4
|
LST1
|
leukocyte specific transcript 1 |
chr12_-_55375622 | 1.03 |
ENST00000316577.8
|
TESPA1
|
thymocyte expressed, positive selection associated 1 |
chr1_+_111770232 | 1.03 |
ENST00000369744.2
|
CHI3L2
|
chitinase 3-like 2 |
chr13_+_28712614 | 1.02 |
ENST00000380958.3
|
PAN3
|
PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
chr3_-_46068969 | 1.02 |
ENST00000542109.1
ENST00000395946.2 |
XCR1
|
chemokine (C motif) receptor 1 |
chr1_+_156123318 | 1.02 |
ENST00000368285.3
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr16_+_50730910 | 1.01 |
ENST00000300589.2
|
NOD2
|
nucleotide-binding oligomerization domain containing 2 |
chr1_+_111770278 | 1.01 |
ENST00000369748.4
|
CHI3L2
|
chitinase 3-like 2 |
chr17_-_61523535 | 1.01 |
ENST00000584031.1
ENST00000392976.1 |
CYB561
|
cytochrome b561 |
chr12_+_112451120 | 1.00 |
ENST00000261735.3
ENST00000455836.1 |
ERP29
|
endoplasmic reticulum protein 29 |
chr6_+_29910301 | 0.99 |
ENST00000376809.5
ENST00000376802.2 |
HLA-A
|
major histocompatibility complex, class I, A |
chr7_+_1272522 | 0.97 |
ENST00000316333.8
|
UNCX
|
UNC homeobox |
chr19_-_4902877 | 0.97 |
ENST00000381781.2
|
ARRDC5
|
arrestin domain containing 5 |
chr1_+_24118452 | 0.95 |
ENST00000421070.1
|
LYPLA2
|
lysophospholipase II |
chr11_-_57194218 | 0.95 |
ENST00000529554.1
|
SLC43A3
|
solute carrier family 43, member 3 |
chr12_+_57623869 | 0.94 |
ENST00000414700.3
ENST00000557703.1 |
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial) |
chr1_-_159893507 | 0.94 |
ENST00000368096.1
|
TAGLN2
|
transgelin 2 |
chr12_+_5541267 | 0.94 |
ENST00000423158.3
|
NTF3
|
neurotrophin 3 |
chr2_+_137523086 | 0.93 |
ENST00000409968.1
|
THSD7B
|
thrombospondin, type I, domain containing 7B |
chr15_-_50411412 | 0.93 |
ENST00000284509.6
|
ATP8B4
|
ATPase, class I, type 8B, member 4 |
chr15_+_80215113 | 0.92 |
ENST00000560255.1
|
C15orf37
|
chromosome 15 open reading frame 37 |
chr1_+_26872324 | 0.92 |
ENST00000531382.1
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
chr15_-_41408409 | 0.92 |
ENST00000361937.3
|
INO80
|
INO80 complex subunit |
chr7_-_100425112 | 0.92 |
ENST00000358173.3
|
EPHB4
|
EPH receptor B4 |
chr17_-_27044810 | 0.91 |
ENST00000395242.2
|
RAB34
|
RAB34, member RAS oncogene family |
chr3_-_124839648 | 0.91 |
ENST00000430155.2
|
SLC12A8
|
solute carrier family 12, member 8 |
chr19_+_45254529 | 0.90 |
ENST00000444487.1
|
BCL3
|
B-cell CLL/lymphoma 3 |
chr6_+_31554612 | 0.89 |
ENST00000211921.7
|
LST1
|
leukocyte specific transcript 1 |
chr6_-_112115103 | 0.88 |
ENST00000462598.3
|
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr21_+_34775698 | 0.88 |
ENST00000381995.1
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr17_+_43209967 | 0.87 |
ENST00000431281.1
ENST00000591859.1 |
ACBD4
|
acyl-CoA binding domain containing 4 |
chr12_+_112451222 | 0.87 |
ENST00000552052.1
|
ERP29
|
endoplasmic reticulum protein 29 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0060621 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.8 | 2.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.7 | 3.0 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.7 | 7.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.7 | 1.3 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.6 | 4.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.6 | 1.2 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.6 | 4.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.5 | 4.4 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.5 | 7.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.5 | 1.6 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.5 | 1.6 | GO:0072573 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
0.5 | 4.6 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.5 | 37.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.4 | 1.3 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.4 | 1.3 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.4 | 4.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 2.7 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.4 | 2.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.4 | 1.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.4 | 1.9 | GO:0043335 | protein unfolding(GO:0043335) |
0.4 | 0.7 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
0.4 | 5.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 1.1 | GO:0070266 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.4 | 2.6 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.4 | 1.1 | GO:0032903 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.4 | 1.1 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 1.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 1.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.3 | 2.0 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.3 | 6.9 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.3 | 1.0 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.3 | 4.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.2 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.3 | 0.9 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.3 | 3.9 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 2.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 0.8 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
0.3 | 0.8 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.3 | 1.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 1.1 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.3 | 7.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 6.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 1.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.2 | 0.7 | GO:0090427 | activation of meiosis(GO:0090427) |
0.2 | 1.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.2 | 0.9 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 27.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.7 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.2 | 0.4 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.2 | 3.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 2.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 2.5 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 0.6 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) histone H3-K9 deacetylation(GO:1990619) |
0.2 | 0.6 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) activation of protein kinase C activity(GO:1990051) |
0.2 | 1.0 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.2 | 1.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.5 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.5 | GO:1902997 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.2 | 3.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 1.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.2 | 0.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.5 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.2 | 0.5 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.2 | 0.7 | GO:0060032 | notochord regression(GO:0060032) |
0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 1.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.2 | 0.7 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.2 | 2.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 2.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.4 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.1 | 1.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.8 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 1.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.8 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 1.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 1.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 0.4 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.1 | 1.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 1.7 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 3.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.4 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.1 | 1.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.4 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 0.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 1.1 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 2.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 3.1 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.1 | 2.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 10.5 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.1 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 1.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 1.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.4 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) positive regulation of memory T cell differentiation(GO:0043382) positive regulation of T-helper 17 cell differentiation(GO:2000321) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.1 | 3.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.2 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 1.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 2.0 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 3.4 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.2 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.1 | 2.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.2 | GO:0072278 | thyroid-stimulating hormone secretion(GO:0070460) metanephric comma-shaped body morphogenesis(GO:0072278) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 1.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.9 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.2 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.1 | 1.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.6 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.1 | 0.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 3.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.9 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.3 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.3 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.1 | 0.6 | GO:0016050 | vesicle organization(GO:0016050) |
0.1 | 0.2 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.0 | 1.6 | GO:0042092 | type 2 immune response(GO:0042092) |
0.0 | 1.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.0 | 1.5 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 1.1 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.0 | 1.7 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 1.9 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 1.1 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 0.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 4.6 | GO:0031295 | T cell costimulation(GO:0031295) |
0.0 | 1.8 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.7 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.7 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 1.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.5 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.0 | 0.2 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.4 | GO:0007631 | feeding behavior(GO:0007631) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.4 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.0 | 0.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.7 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 2.4 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.6 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 1.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.0 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 2.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 3.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 1.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.0 | 0.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.8 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.0 | 0.7 | GO:0006914 | autophagy(GO:0006914) |
0.0 | 2.2 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 1.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 1.3 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 1.0 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.1 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 1.1 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.0 | 1.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 1.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 1.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) endothelial cell activation(GO:0042118) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.9 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 1.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.3 | GO:0035458 | positive regulation of protein import into nucleus, translocation(GO:0033160) cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.6 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 1.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.5 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 1.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 1.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.3 | GO:0001964 | startle response(GO:0001964) |
0.0 | 1.2 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 2.9 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.8 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.4 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 2.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 37.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.7 | 7.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 4.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 1.1 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.3 | 3.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 7.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 4.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 3.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.2 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.3 | 4.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 1.1 | GO:0045160 | myosin I complex(GO:0045160) |
0.3 | 1.9 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.3 | 3.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 1.0 | GO:0031251 | PAN complex(GO:0031251) |
0.2 | 0.7 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 2.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 1.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 2.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 4.3 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.2 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 3.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 2.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.2 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 3.1 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 0.7 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 2.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.7 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.1 | 0.4 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 5.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 1.2 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 13.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 6.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.2 | GO:0070685 | macropinocytic cup(GO:0070685) |
0.1 | 1.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 1.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 3.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 3.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 1.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 2.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.1 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.0 | 1.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 1.6 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.6 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.6 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.9 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 9.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 2.6 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 3.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.5 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.7 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 7.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 4.3 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 1.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.8 | 3.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.6 | 39.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.5 | 1.6 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.5 | 4.6 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 2.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 2.7 | GO:0046979 | TAP2 binding(GO:0046979) |
0.4 | 1.6 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 1.1 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.3 | 5.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.3 | 1.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.3 | 0.8 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.3 | 4.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 1.3 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.3 | 1.8 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.3 | 1.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.2 | 1.7 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 0.7 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.2 | 1.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 1.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 4.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.6 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.2 | 1.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 1.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 4.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 34.6 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 2.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 6.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 2.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 3.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.2 | 4.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 1.5 | GO:0004672 | protein kinase activity(GO:0004672) |
0.1 | 1.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 2.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 1.5 | GO:0035005 | lipid kinase activity(GO:0001727) 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.3 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 3.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 2.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.7 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.1 | 0.4 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.1 | 3.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 1.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 0.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 4.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 4.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 2.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 3.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 1.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 3.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 2.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 1.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 1.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.2 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 2.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 4.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 2.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 1.9 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.5 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.0 | 4.7 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.0 | 0.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 1.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.3 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.0 | 0.2 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.0 | 1.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 1.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 1.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 1.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 1.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.1 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.0 | 2.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 1.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 4.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.5 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 4.5 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 3.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 1.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 1.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 1.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 8.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 8.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 6.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 2.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 12.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 2.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 3.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 7.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 2.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 2.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 3.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 6.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 4.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 7.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 5.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 4.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 8.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 4.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.6 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 4.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 3.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 4.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 7.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 2.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 6.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 3.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 3.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 1.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 1.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 2.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 3.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 1.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 5.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.9 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 2.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 1.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |